Safety requirements for maintenance and distribution of transgenic mice susceptible to human viruses: The example of poliovirus-susceptible transgenic mice

Current Topics in Microbiology and Immunology

Volumn 206, Issue , 1996, Pages 326-340

  Ghendon, Y ^a   Lambert, P H ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MUS MUSCULUS; POLIOVIRUS; ANIMALIA;

POLIOMYELITIS VACCINE;

DISEASE PREDISPOSITION; EXPERIMENTAL ANIMAL; MOUSE; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK; SAFETY; TRANSGENIC MOUSE; VIRULENCE; VIRUS GENOME;

ANIMALS; CONTAINMENT OF BIOHAZARDS; GENOME, VIRAL; HUMANS; MICE; MICE, TRANSGENIC; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; PUBLIC HEALTH; RISK FACTORS; VIRULENCE;

EID: 4243139784     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-85208-4_16     Document Type: Article

References (30)

1. Abramczuk JW, Penson DS, Leonard J, Monell-Torrens E, Belcher J, Martin M, Notkins AL (1992) Transgenic mice carrying intact HIV provirus. biological effects and organization of a transgene J Acquir Innume Defic Syndr 5: 196-203
2. Aguzzi A, Wagner EF, Williams R, Courtheidge SA (1990) Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen New Biol 2: 533-543
3. Aguzzi A, Bothe K, Anthauser I, Horak I, Rethwilm A, Wagner E (1992) Expression of human foamy virus is differentially regulated during development in transgenic mice New Biol 4: 225-237
4. Animals Scientific Procedures Act (UKJ); Animal Welfare Act (USA), Law Concerning the Protection and Control of Animals (Japan), Tier Schutzgestetz (Germany), The UFAW Handbook on the Care and Management of Laboratory Animals (YFAW, UK), Guide for the Care and Use of Laboratory Animals (UFAW, UK); Guide for the Care and Use of Laboratory Animals (ILAR, USA); Standards Relating to the Care and Management of Experimental Animals (Prime Minister's Office, Japan); International Guiding Principles for Biomedical Research Involving Animals (CIOMS); Laws regulating Genetic Engineering Issues in the FRG, Society for Laboratory Animal Science: Zur Planung und Structur von Versuchstierbereichen tierexperimentell tatiger Institutionen 1988; WHO/ICLAS Guidelines for the Establishment of Animal Colonies and Use of Laboratory Animals (WHO, Geneva, in preparation)
5. Araki K, Nishimura S, Ochiya T, Okybo K, Miyazaki J, Matsubara K, Yamamura K (1991) Production and effect of infectious Dane particles in transgenic mice Jpn J Cancer Res 82: 235-239
6. Beggs AH, Miner JH, Scangos GA (1990) Cell type-specific expression of JC virus T antigen in primary and established cell lines from transgenic mice. J Gen Virol 71: 151-164
7. Bills ND, Hinrichs SH, Morgan R, Clifford AJ (1992) Delayed tumor onset in transgenic mice fed a low-folate diet J Natl Cancer Inst 84: 332-337
8. Choo KB, Liew LN, Chong KY, Lu RH, Cheng WT (1991) Transgenome transcription and replication in the liver and extrahetatic tissues of a human hepatitis B virus transgenic mouse. Virology 182: 785-792
9. Choo KB, Chong KY, Liew LN, Hsu HC, Cheng WT (1992) Unregulated and basal transcriptional activities of the regulatory sequence of the type 18 human papillomavirus genome in transgenic mice Virology 188: 378-383
10. Dunsford HA, Sell S, Chisari FV (1990) Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice Cancer Res 50 3400-3407
11. Genetic Manipulation Guidelines on Work with Transgenic Animals (Home Office, UK), Guidelines for Recombinant DNA Experiments (Ministry of Education, Science and Culture, Japan); Cornell directive on the contained use of genetically modified micro organisms (USA), Laws Regulating Genetic Engineering Issues in the FRG Gonzalez-Dunia D, Grimber G, Briard P, Brahic M, Ozden S (1992) Tissue expression pattern directed in transgenic mice by the LTR of an HTLV-1 provirus isolated from a case of tropical spastic paraparesis Virology 187: 705-710
12. Live Animal Regulations (IATA): The UFAW Handbook on the Care and Management of Laboratory Animals (UFAW, UK): Guide for the Care and Use of Laboratory Animals (ILAR, USA); Standards Relation to the Care and Management of Experimental Animals (Prime Minister's Office, Japan); International Guiding Principles for Biomedical Research Involving Animals (CIOMS); WHO/ICLAS Guidelines for the Establishment of Animal Colonies and Use of Laboratory Animals, Chapter 14 (WHO, Geneva, in preparation)
13. Furth PA, Hennighausen L, Baker C, Beatty B, Woychick R (1991) The variability in activity of the universally expressed human cytomegalovirus immediate early gene I, enhancer/promoter in transgenic mice. Nucleic Acids Res 19: 6205-6208
14. International Guiding Principles for Biomedical Research Involving Animals, CIMS, Geneva 1985
15. Iwakura Y, Tosu M, Yoshida E, Takiguchi M, Sato K, Kitajima I (1991) Induction of inflammatory arthrpathy resembling rheumatoid arthritis in mice transgenic for HTLV-1. Science 253: 1026-1028
16. Jolicoeur P, Laperriere A, Beaulieu N (1992) Efficient production of human immunodeficiency virus proteins in transgenic mice. J Virol 66: 3904-3908
17. Koike K, Jay G, Hartley JW, Schrenzel MD, Higgins R, Hinrichs S (1990) Activiation of retrovirus in transgenic mice. association with development of olfactory neuroblastoma J Virol 64: 3988-3991
18. Koike S, Taya C, Kurata T, Abe S, Ise I, Yonekawa H, Nomoto A (1991) Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci USA 88: 951-955
19. Koike S, Horie H (1993) Poliovirus-sensitive transgenic mice as a new animal model In Brown F, Lewis BP (eds) Poliovirus Attenuation Molecular Mechanisms and Practical Aspects Dev Biol Stand Basel, Karger, 78, pp 101-107
20. Lee TH, Finegold MJ, Shen R, DeMayo JL, Woo SL, Butel JS (1990) Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice J Virol 64: 5939-5947
21. Leonard JM, Abramczuk JW, Pezen D, Rutledge R, Belcher J, Hakim F (1988) Development of disease and virus recovery in transgenic mice containing proviral DNA Science 242: 1665-1770
22. Maintenance and distribution of transgenic mice susceptible to human viruses (1993) WHO Bulletin 71: 497-502
23. Morrey JD, Bourn SM, Bunch TD, Jackson MK, Sidwell R, Barrows L, Daynes R, Rosen CA (1991) In vivo activation of human immunodeficiency virus type 1 long terminal repeat report by UV type A(UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. J Virol 65: 5045-5051
24. Ren R, Costantini F, Gorgacz E, Lee JJ, Racaniello VR (1990) Transgenic mice expressing a human poliovirus receptor a new model for poliomyelitis. Cell 63: 353-362
25. Small JA, Bieberich C, Chotbi Z, Hess J, Scangos G, Clements JE (1989) The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes, and the central nervous systems of transgenic mice. Virol 63: 1891-1896
26. Tinsley JM, Fisher C, Searle PF (1992) Abnormalaties of epidermal differentiation associated with expression of the human papillomavirus type 1 early region in transgenic mice J Gen Virol 73: 1251-1260
27. Vogel J, Hinrichs SH, Napolitano L, Ngo L, Jay G (1991) Liver cancer in transgenic mice carrying the human immunodeficiency virus tat gene Cancer Res 51: 6686-6690
28. Vogel J, Cepeda M, Tschachler E, Napolitano L, Jay G (1992) UV activation of human immunodeficiency virus gene expression in transgenic mice J Virol 66: 1-5
29. WHO/ICLAS Guidelines for Maintenance of Animals (1992) WHO, Geneva
30. Wilson JB, Weinbegr W, Jonson R, Yuspa S, Levine A (1990) Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6 Cell 61: 1315-1327